Issue compulsory licences for manufacture of Ramdesivir, CPI(M) tells govt.

sfg-2026
ForumIAS LATEST
      1. SFG FRC 2027 | Program starts from 19th Dec. 2026 | Admissions open for Entrance Test Click Here to know more →
      2. Prelims Test Series (PTS) for Prelims 2027 starts 11th Oct. 2026 Click Here to know more →
      3. [Pre-order] Ethics Redbook 3rd Edition: Delivery starts from 10th October onwards Click Here to Read More →
      4. 21 Sept. | GS Advance Program (GSAP) for UPSC 2027 Mains starts from 11th Oct. Click Here to Read More →

News: CPI(Marxist) has said that the government should issue compulsory licences for the manufacture of a generic version of Remdesivir, an antiviral drug being used to treat COVID-19 patients.

Facts:

  • Compulsory licensing(CL): It is a process where a government allows someone else to produce the patented product or process without the consent of the patent owner. 
    • It is one of the flexibility on patent protection included in the WTO’s agreement on intellectual property –TRIPS  Agreement.
  • Section 84 of the (Indian) Patent Act,1970 provides that any time after three years from date of sealing of a patent, application for compulsory license can be made,provided:
    • the reasonable requirements of the public with respect to the patented invention have not been satisfied
    • the patented invention is not available to the public at a reasonably affordable price
    • patented invention has not worked in the territory of India.
  • Section 92 of the (Indian) Patent Act,1970 provides that compulsory licenses can also be issued by the Government if there is either a “national emergency” or “extreme urgency” or in cases of “public non-commercial use”.
Print Friendly and PDF
Blog
Academy
Community